Live Complimentary Webinar: Panel Discussion: Search, Analytics and SEND: Guarding Your Drug Safety Blind Spots

Tuesday, February 28, 2012, 11am ET
Duration: 60 minutes

Sponsored by:

 

 

Join us for DSEC's complimentary February webinar continuing our focus on the FDA SEND Initiative.

Register here

The FDA has announced its intent to mandate nonclinical data submissions in standardized formats like SEND. Consequently, Agency reviewers expect to be spending more time on data analysis and detection of potential safety signals across studies. To guard against blind spots in your drug development lifecycle, wouldn’t you want to search, view and analyze your study data according to the new FDA standards? In this webinar, experts will discuss ways to improve the science of early safety signal detection, while assuring compliance with regulatory data submission requirements.

Panelists Include:

• Michael Brennan, Director of Informatics, Johnson & Johnson
• Gitte Frausing, Regulatory Professional, NovoNordisk
• Shree Nath, Vice President, PointCross Life Sciences
• Moderator: Ernie Bush, CSO, Drug Safety Executive Council

Register now to attend this complimentary 60-minute session. 

About DSEC
DSEC is a peer membership of over 2,000 drug safety leaders with the common objective of advancing the development of better and safer medicines. Membership is complimentary and limited to employees of pharmaceutical companies. DSEC also manages several industry consortia of biopharmaceutical companies that qualify preclinical safety platforms. Learn more at www.drugsafetycouncil.org.